US 11013740
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
granted A61KA61K31/505A61K33/24
Quick answer
US patent 11013740 (Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy) held by The Board of Regents of the University of Texas System expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/505, A61K33/24, A61K33/243